The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016

June 1, 2010

According to its press release GBI Research has found that the global ophthalmology market will grow at a moderate rate due to the impact of generic erosion in some markets such as glaucoma and allergic conjunctivitis.

According to its press release GBI Research has found that the global ophthalmology market will grow at a moderate rate due to the impact of generic erosion in some markets such as glaucoma and allergic conjunctivitis. However, the unmet need in the macular degeneration and macular edema markets make the ophthalmology market attractive despite generic erosion. The attractiveness of the macular degeneration and macular edema markets is evident from the considerable amount of research and development activity for these indications. The major factor driving the growth of the market is the rising awareness about the importance of detecting ophthalmic diseases early, the availability of effective diagnostic tools and an increase in the prevalence of diabetes. The expiry of blockbuster drugs’ patents and increasing pressure from cheap off-label products in some markets will be the key restraints for the market.

Read more here